COMPLEX COMPRISING OSTEOCLASTOGENESIS-INHIBITORY FACTOR (OCIF) AND POLYSACCHARIDE

FIELD: medicine, medicinal preparations, pharmacy. ^ SUBSTANCE: invention proposes a new complex comprising at least one substance taken among the group: osteoclastogenesis-inhibitory factor (OCIF), its analogues and its variants that are bound with a substance taken among the group consisting of po...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MOTIZUKI SINITI, MIJAZAKI KHIDEKI, NISI KHIROTAKA, NUMAZAVA TAKU, TSUDA EISUKE, KURIKHARA ATSUSI, JAMAMOTO SINITI, KONDO DZUNITI, OKADA DZUNITI
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES OF PREPARING SUCH COMPOSITIONS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine, medicinal preparations, pharmacy. ^ SUBSTANCE: invention proposes a new complex comprising at least one substance taken among the group: osteoclastogenesis-inhibitory factor (OCIF), its analogues and its variants that are bound with a substance taken among the group consisting of polysaccharides and their derivatives. The complex exhibits property for prolonged retention in blood stream after its administration that provides its applicability in treatment and prophylaxis of osseous metabolic diseases. The complex provides normalization of osseous metabolism. ^ EFFECT: valuable medicinal properties of complex, expanded assortment of agents. ^ 34 cl, 8 tbl, 8 ex